跳至主要内容
临床试验/NCT02323321
NCT02323321已完成不适用

International Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS™) Heart For Preserving and Assessing Expanded Criteria Donor Hearts for Transplantation (EXPAND Heart Trial)

TransMedics11 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2015年9月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
TransMedics
入组人数
75
试验地点
11
主要终点
Patient Survival at Day-30 Post Transplant and Absence of Severe Primary Heart Graft Dysfunction in the First 24 Hours Post-transplantation

研究概览

简要总结

To evaluate the effectiveness of the OCS™ Heart to recruit, preserve and assess donor hearts that may not meet current standard donor heart acceptance criteria (as identified above) for transplantation to potentially improve donor heart utilization for transplantation

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Registered male or female primary Heart transplant candidate
  • •Age ≥18 years old

排除标准

  • •Prior solid organ or bone marrow transplant
  • •Chronic use of hemodialysis or diagnosis of chronic renal insufficiency
  • •Multi-organ transplant

研究组 & 干预措施

OCS Preservation

Experimental

OCS Preservation and Assessment

干预措施: Preservation of Hearts for Transplantation (Device)

结局指标

主要结局

Patient Survival at Day-30 Post Transplant and Absence of Severe Primary Heart Graft Dysfunction in the First 24 Hours Post-transplantation

时间窗: 30 Days

A composite endpoint of patient survival at Day-30 post-transplant and absence of severe heart primary graft dysfunction (PGD) (left or right ventricle)) in the first 24 hours post-transplantation.

次要结局

未报告次要终点

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验